Literature DB >> 8939933

Identification of a novel RalGDS-related protein as a candidate effector for Ras and Rap1.

S N Peterson1, L Trabalzini, T R Brtva, T Fischer, D L Altschuler, P Martelli, E G Lapetina, C J Der, G C White.   

Abstract

Although Ras and Rap1 share interaction with common candidate effector proteins, Rap1 lacks the transforming activity exhibited by Ras proteins. It has been speculated that Rap antagonizes Ras transformation through the formation of nonproductive complexes with critical Ras effector targets. To understand further the distinct biological functions of these two closely related proteins, we searched for Rap1b-binding proteins by yeast two-hybrid screening. We identified multiple clones that encode the COOH-terminal sequences of a protein that shares sequence identity with RalGDS and RGL, which we have designated RGL2. A 158-amino acid COOH-terminal fragment of RGL2 (RGL2 C-158) bound to Ras superfamily proteins which shared identical effector domain sequences with Rap1 (Ha-Ras, R-Ras, and TC21). RGL2 C-158 binding was impaired by effector domain mutations in Rap1b and Ha-Ras. Furthermore, RGL2 C-158 bound exclusively to the GTP-, but not the GDP-bound form of Ha-Ras. Finally, coexpression of RGL2 C-158 impaired oncogenic Ras activation of transcription from a Ras-responsive promoter element and focus-forming activity in NIH 3T3 cells. We conclude that RGL2 may be an effector for Ras and/or Rap proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939933     DOI: 10.1074/jbc.271.47.29903

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Structure characterization of human RalGDS gene, and the identification of its novel variant.

Authors:  Q Zheng; L Yu; Y Zhao; H Zhang; Q Fu; N Mao; P Hu; Z Geng; S Zhao
Journal:  Mol Biol Rep       Date:  2000       Impact factor: 2.316

2.  Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis.

Authors:  I Treinies; H F Paterson; S Hooper; R Wilson; C J Marshall
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 3.  Ral GTPases in tumorigenesis: emerging from the shadows.

Authors:  David F Kashatus
Journal:  Exp Cell Res       Date:  2013-07-02       Impact factor: 3.905

4.  A combined yeast/bacteria two-hybrid system: development and evaluation.

Authors:  Ilya G Serebriiskii; Rui Fang; Ekaterina Latypova; Richard Hopkins; Charles Vinson; J Keith Joung; Erica A Golemis
Journal:  Mol Cell Proteomics       Date:  2005-03-20       Impact factor: 5.911

5.  The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery.

Authors:  Nicole F Neel; Timothy D Martin; Jeran K Stratford; Tanya P Zand; David J Reiner; Channing J Der
Journal:  Genes Cancer       Date:  2011-03

6.  Transcriptional regulation of the TATA-binding protein by Ras cellular signaling.

Authors:  S A Johnson; N Mandavia; H D Wang; D L Johnson
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

7.  Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts.

Authors:  Y Tang; J Yu; J Field
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

8.  A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors.

Authors:  Gromoslaw A Smolen; Benjamin J Schott; Rodney A Stewart; Sven Diederichs; Beth Muir; Heather L Provencher; A Thomas Look; Dennis C Sgroi; Randall T Peterson; Daniel A Haber
Journal:  Genes Dev       Date:  2007-08-17       Impact factor: 11.361

Review 9.  Human RAS superfamily proteins and related GTPases.

Authors:  John Colicelli
Journal:  Sci STKE       Date:  2004-09-07

10.  Differential effects of protein kinase A on Ras effector pathways.

Authors:  M J Miller; L Rioux; G V Prendergast; S Cannon; M A White; J L Meinkoth
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.